Yes. A US-licensed clinician can prescribe an oral GLP-1 medication for weight loss through a legitimate telehealth intake, the same way one would prescribe an injectable version. Right now there are two FDA-approved tablets available this way — the Wegovy® pill (semaglutide) and Foundayo™ (orforglipron) — plus, through some telehealth providers including Pallas, a compounded oral semaglutide tablet as a separate option. Every legitimate path starts the same way: an online health questionnaire that a licensed clinician reviews before anything is prescribed.
The short answer
Two oral GLP-1 medications are FDA-approved for chronic weight management: the Wegovy® pill (semaglutide, Novo Nordisk) and Foundayo™ (orforglipron, Eli Lilly). A compounded oral semaglutide tablet is also available through some telehealth providers as a separate, non-equivalent §503A option. A licensed clinician reviews your health history online and prescribes whichever option, if any, is appropriate — no in-person visit is required in most states.
What counts as an "oral GLP-1 medication"?
Three distinct things get called this, and they're not interchangeable:
| Option | Molecule | Regulatory tier | How it's taken |
|---|---|---|---|
| Wegovy® pill | Semaglutide | FDA-approved | Once daily, on an empty stomach with a sip of water, then a 30-minute wait before eating |
| Foundayo™ | Orforglipron | FDA-approved | Once daily, any time of day, with or without food |
| Compounded oral semaglutide | Semaglutide | Compounded (FDCA §503A) | Once daily, as directed by your clinician |
The Wegovy® pill and Foundayo™ are approved by the FDA and manufactured by Novo Nordisk and Eli Lilly, respectively. The compounded tablet is prepared per-patient by a US-licensed compounding pharmacy, not manufactured by either company, and is a separate product under separate regulation — not a generic or lower-cost version of either brand pill.
How does an online oral GLP-1 prescription actually work?
The process doesn't change based on the form of the medication:
- Complete a health questionnaire. You'll share your medical history, current medications, any prior GLP-1 use, and your state of residence — a clinician must be licensed where you're physically located.
- A US-licensed clinician reviews it. This is a clinical decision based on your history, not a formality. Eligibility is determined by a US-licensed clinician.
- If appropriate, a prescription goes to a licensed pharmacy. Which pharmacy depends on which medication is prescribed and your location.
- The pharmacy fills and ships your prescription. Most intakes take 5–10 minutes, and many states allow the entire process — including the clinician's review — to happen without a live video visit. See our full guide to how online GLP-1 prescriptions work for the state-by-state details.
The FDA-approved oral options: the Wegovy® pill and Foundayo™
The Wegovy® pill is Novo Nordisk's tablet form of semaglutide, FDA-approved in December 2025 for chronic weight management in adults with obesity, or overweight with at least one weight-related condition, alongside a reduced-calorie diet and increased activity. Like other oral semaglutide tablets, it's taken on an empty stomach with a small sip of water, then a 30-minute wait before eating or taking other medications.
Foundayo™ (orforglipron) is Eli Lilly's small-molecule GLP-1 pill, FDA-approved in April 2026 for the same chronic-weight-management indication. Chemically, it's sturdy enough to survive digestion without the Wegovy® pill's food-and-water timing rules — it can be taken any time of day, with or without food. Read our full explainer on Foundayo™ for how it works and what its trial showed.
Both are prescription-only and dispensed by licensed pharmacies after a clinician determines one is appropriate for you. Learn more about GLP-1 treatment at Pallas, including the Wegovy® pill and Foundayo™ pages.
Is there a compounded oral GLP-1 option?
Yes, in a separate tier. A compounded oral semaglutide tablet is prepared per-patient by a US-licensed compounding pharmacy under FDCA §503A, when a clinician documents a patient-specific clinical rationale for it over an FDA-approved option. It's a daily tablet, with no injection, but it is a different and separately regulated product from the Wegovy® pill — not a generic version, not an equivalent, and not a lower-cost substitute for it.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.
Whether a compounded tablet, an FDA-approved pill, or an injection is the right fit is a decision your clinician makes after reviewing your history — not a matter of which one costs less or which one you'd rather take.
Does insurance cover an oral GLP-1 prescription?
It depends on the medication, the pharmacy, and your plan. Through a standard pharmacy, coverage for the Wegovy® pill varies by insurer, and many commercial plans require prior authorization or exclude weight-loss indications entirely; compounded medications are generally not covered by insurance at all. Medicare is prohibited by law from covering medications prescribed for weight loss.
Through Pallas, the Wegovy® pill is $299 for your first month, then $499 every 4 weeks; Foundayo™ is $299 for your first month, then $499 every 4 weeks. Both are cash-pay only and not billed to insurance. Compounded oral semaglutide, when appropriate, starts at $299 a month — see our full compounded semaglutide cost breakdown for every cadence.
How do I know an online oral GLP-1 prescriber is legitimate?
The warning signs are the same regardless of which tablet is being sold:
- No health questionnaire, or a clinician who approves everyone. A real clinical review asks about your history and can say no.
- No named, licensed pharmacy. A legitimate provider can tell you exactly which pharmacy fills your prescription.
- "Research use only" tablets, or no prescription required at all. Every oral GLP-1 medication discussed here is prescription-only in the US.
- No verifiable certification. LegitScript maintains a public database of certified healthcare merchants — check any provider, including Pallas, before paying.
Where does Pallas fit?
Pallas's US-licensed clinicians can prescribe the FDA-approved Wegovy® pill, Foundayo™, the Wegovy® and Zepbound® pens and their siblings, or compounded semaglutide and tirzepatide — injectable or, when appropriate, a compounded oral tablet — based on your intake. Eligibility is determined by a US-licensed clinician, and a licensed pharmacy fills and ships whichever prescription is issued.
Bottom line: A licensed clinician can prescribe an oral GLP-1 medication online — the FDA-approved Wegovy® pill or Foundayo™, or, when appropriate, a separate compounded oral semaglutide tablet. All three are prescription-only, all three go through the same health-questionnaire-and-clinician-review process, and none of them is a substitute for the others.
Trademarks & disclosures
Wegovy® is a registered trademark of Novo Nordisk A/S; Foundayo™ is a trademark of Eli Lilly and Company. Pallas is not affiliated with, endorsed by, or sponsored by either company. Brand-name medication dispensed through Pallas is cash-pay only and is not billed to insurance. Prescriptions — brand-name or compounded — are written only when a US-licensed clinician determines treatment is appropriate.
